The Food and Drug Administration approved Inovio Pharmaceuticals' treatment for a rare respiratory condition
No summary is available for this story.
More context
The Food and Drug Administration on Friday approved Inovio Pharmaceuticals' treatment for a rare respiratory condition, marking the company's first approval, Reuters reported. Reuters' headline described the condition as a rare throat disease and said Inovio shares surged after the decision.
Was this story useful?
What was the main problem? (optional)
Reporting
Verifier’s note
Reuters reports that the FDA approved Inovio’s treatment for a rare respiratory condition, consistent with the proposed event. TradingView carries the same Reuters report rather than independent reporting.